Evaxion A (EVAX) Other Gross PP&E Adjustments (2020 - 2022)
Evaxion A posted quarterly Other Gross PP&E Adjustments of $4.7 million for Q2 2022, up 127.55% year-on-year from $2.1 million in Q2 2021, and down 7.57% on a QoQ basis from $5.1 million in Q1 2022.
Evaxion A (EVAX) has 3 years of Other Gross PP&E Adjustments data on file, last reported at $4.7 million in Q2 2022.
- For the quarter ending Q2 2022, Other Gross PP&E Adjustments rose 127.55% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2022 stood at $4.7 million (up 127.55% YoY), and the FY2021 full-year result was $5.2 million, up 2241.18% from the prior year.
- Other Gross PP&E Adjustments for Q2 2022 stood at $4.7 million, down from $5.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $5.2 million in Q4 2021 and bottomed at $221000.0 in Q4 2020.
- The 3-year median for Other Gross PP&E Adjustments is $4.7 million (2022), against an average of $3.4 million.
- The widest annual swing landed in 2021, when Other Gross PP&E Adjustments surged 2241.18%; it then soared 127.55% in 2022.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at $221000.0 in 2020, then soared by 2241.18% to $5.2 million in 2021, then dropped by 8.7% to $4.7 million in 2022.
- The last three Other Gross PP&E Adjustments figures came in at $4.7 million (Q2 2022), $5.1 million (Q1 2022), and $5.2 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -75.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 4.72 Mn |
| Jun 30, 2022 | 4.72 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | 221,000.00 |
| Dec 31, 2020 | 221,000.00 |